SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-06-000832
Filing Date
2006-04-19
Accepted
2006-04-19 16:38:38
Documents
5
Period of Report
2006-05-18
Effectiveness Date
2006-04-19

Document Format Files

Seq Description Document Type Size
1 d19050_nps.htm DEF 14A 282502
2 GRAPHIC avant_logo.jpg GRAPHIC 3818
3 GRAPHIC catlin_sig.jpg GRAPHIC 3408
4 GRAPHIC d19050line.jpg GRAPHIC 24004
5 GRAPHIC ward_sig.jpg GRAPHIC 4224
  Complete submission text file 0001206774-06-000832.txt   333440
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 06767628
SIC: 2835 In Vitro & In Vivo Diagnostic Substances